Articles by Disease (Epilepsy)

Purinergic Signalling: What is Missing and Needed Next? The Use of Transgenic Mice, Crystallographic Analysis and MicroRNA

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11
Page: 751-767
Author(s): C. Volonte, C. Parisi and G. Burnstock

P2X7 Receptors: Channels, Pores and More

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11
Page: 705-721
Author(s): C. Volonte, S. Apolloni, S. D. Skaper and G. Burnstock

Glutamate Transporter 1: Target for the Treatment of Alcohol Dependence

Journal: Current Medicinal Chemistry
Volume: 19
Page: 5148-5156
Author(s): P.S.S. Rao and Y. Sari

Anticholinergic Effects of Oral Antipsychotic Drugs of Typicals Versus Atypicals Over Medium- and Long-Term: Systematic Review and Meta-Analysis

Journal: Current Medicinal Chemistry
Volume: 19
Page: 5214-5218
Author(s): M. Ozbilen, C.E. Adams and J. Marley

Identification of Novel NaV1.7 Antagonists Using High Throughput Screening Platforms

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 15
Page: 713-720
Author(s): Goran Klement, Olga Babich, Olof Larsson, Per-Eric Lund, Asa Malmberg, Lars Sandberg, Zara A. Sands and Michael Dabrowski

The Canadian Biomarker Integration Network in Depression (CAN-BIND): Advances in Response Prediction

Journal: Current Pharmaceutical Design
Volume: 18
Page: 5976-5989
Author(s): Sidney H. Kennedy, Jonathan Downar, Kenneth R. Evans, Harriet Feilotter, Raymond W. Lam, Glenda M. MacQueen, Roumen Milev, Sagar V. Parikh, Susan Rotzinger and Claudio Soares

Lack of Data on Depression-like States and Antidepressant Pharmacotherapy in Patients with Epilepsy: Randomised Controlled Trials are Badly Needed

Journal: Current Pharmaceutical Design
Volume: 18
Page: 5828-5836
Author(s): Kousuke Kanemoto, Yukari Tadokoro, Abigail J. Sheldrick and Tomohiro Oshima